-The Times of India NEW DELHI: Promptly addressing complaints against hospitals that were allegedly overcharging for stents, the National Pharmaceutical Pricing Authority (NPPA) has issued show-cause notices to Max Hospital, Saket (New Delhi), and Nidaan Hospital, Sonipat (Haryana). While the regulator said that the action is based on the findings of its preliminary investigation, both the hospitals denied the charge and maintained that they have "not overcharged a single patient" for stents. On...
More »SEARCH RESULT
Total Matching Records found : 70
NPPA puts price cap on cardiac stents; says hospitals overcharge -Kundan Pandey
-Down to Earth The average cost of drug eluting stent for domestic companies is around Rs 8,000 but it is sold to patients for Rs 24,000 to Rs 1.5 lakh In a decision that will benefit thousands of people in the country, the National Pharmaceutical Pricing Authority (NPPA) has finally put a ceiling on prices of cardiac stent—a small mesh tube that's used to treat narrow or weak arteries. Cardiac stents...
More »Prices of 50 essential drugs slashed by up to 44%
-PTI NEW DELHI: Prices of over 50 essential drugs including those used for treatment of HIV infection, diabetes, anxiety disorders, bacterial infections, angina and acid reflux have been capped by the government, leading to a price cut in the range of 5 per cent to 44 per cent. The National Drug Pricing Regulator has also fixed the retail prices of 29 formulations. "NPPA has fixed/revised ceiling prices of 55 scheduled formulations of Schedule-I...
More »Government served legal notice over decision to cut NPPA's powers -Prabha Raghavan
-The Economic Times NEW DELHI: Civil society group All India Drug Action Network (AIDAN) has sent legal notices to Niti Aayog CEO and secretaries to the health ministry, department of pharmaceuticals and department of industrial policy and promotion over their talks to cut powers of the National Pharmaceutical Pricing Authority. The group has termed the move “anti-national” and “anti-people”, adding that it affects an ongoing case at the Supreme Court over various...
More »Out of essentials list, prices of 100 drugs may increase by 10% -Sushmi Dey
-The Times of India NEW DELHI: Prices of around 100 medicines, including those for Alzheimer's, diabetes and hypertension, could rise by up to 10% after they were removed from the national list of essential medicines. Though the move is likely to impact consumers, it comes as a relief to drug makers reeling under stringent price regulation for over a year. Overruling a previous order by the drug price regulator, the Centre has...
More »
